<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37510324</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>10</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Apolipoprotein E (ApoE) &#x3b5;4 Genotype (ApoE rs429358-ApoE rs7412 Polymorphisms) Is Not Associated with Long COVID Symptoms in Previously Hospitalized COVID-19 Survivors.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1420</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes14071420</ELocationID><Abstract><AbstractText>The role of genetics as a predisposing factor related to an increased risk of developing long COVID symptomatology is under debate. The aim of the current secondary analysis was to identify the association between the Apolipoprotein E (ApoE) gene, a gene affecting cholesterol metabolism and previously associated with a higher risk of SARS-CoV-2 infection and COVID-19 severity, and the development of long COVID in a cohort of individuals who had been hospitalized by SARS-CoV-2 infection. Unstimulated whole saliva samples were collected from 287 previously hospitalized COVID-19 survivors. Three genotypes of the ApoE gene (ApoE &#x3b5;2, &#x3b5;3, &#x3b5;4) were obtained based on the combination of ApoE rs429358 and ApoE rs7412 polymorphisms. Participants were asked to self-report the presence of any post-COVID symptom in a face-to-face interview at 17.8 &#xb1; 5.2 months after hospital discharge and medical records were obtained. Each participant reported 3.0 (1.9) post-COVID symptoms. Overall, no significant differences in long COVID symptoms were observed depending on the ApoE genotype (ApoE &#x3b5;2, ApoE &#x3b5;3, ApoE &#x3b5;4). The presence of the ApoE &#x3b5;4 genotype, albeit associated with a higher risk of SARS-CoV-2 infection and COVID-19 severity, did not appear to predispose for the presence of long COVID in our cohort of previously hospitalized COVID-19 survivors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3772-9690</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arendt-Nielsen</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Gastroenterology, Mech-Sense, Aalborg University Hospital, DK-9000 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az-Gil</LastName><ForeName>Gema</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Esquer</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5426-4349</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil-Crujera</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1022-5831</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-S&#xe1;nchez</LastName><ForeName>Stella M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0002-7140-4286</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambite-Quesada</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6755-8189</Identifier><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Universidad Rey Juan Carlos, 28922 Alcorc&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palomar-Gallego</LastName><ForeName>Mar&#xed;a A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-4018-2270</Identifier><AffiliationInfo><Affiliation>Research Group GAMDES, Department of Basic Health Sciences, Universidad Rey Juan Carlos (URJC), 28922 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellicer-Valero</LastName><ForeName>Oscar J</ForeName><Initials>OJ</Initials><Identifier Source="ORCID">0000-0002-0104-1029</Identifier><AffiliationInfo><Affiliation>Image Processing Laboratory (IPL), Universitat de Val&#xe8;ncia, Parc Cient&#xed;fic, Paterna, 46100 Val&#xe8;ncia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giordano</LastName><ForeName>Rocco</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1331-129X</Identifier><AffiliationInfo><Affiliation>Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053329">Apolipoprotein E2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053327">Apolipoprotein E4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053329" MajorTopicYN="N">Apolipoprotein E2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053327" MajorTopicYN="N">Apolipoprotein E4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="Y">Apolipoproteins E</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ApoE</Keyword><Keyword MajorTopicYN="N">genotype</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">single nucleotide polymorphism</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37510324</ArticleId><ArticleId IdType="pmc">PMC10379077</ArticleId><ArticleId IdType="doi">10.3390/genes14071420</ArticleId><ArticleId IdType="pii">genes14071420</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Glotov O.S., Chernov A.N., Scherbak S.G., Baranov V.S. Genetic risk factors for the development of COVID-19 coronavirus infection. Russ. J. Genet. 2021;57:878&#x2013;892. doi: 10.1134/S1022795421080056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S1022795421080056</ArticleId><ArticleId IdType="pmc">PMC8404752</ArticleId><ArticleId IdType="pubmed">34483599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira de Ara&#xfa;jo J.L., Menezes D., Saraiva-Duarte J.M., de Lima F.L., Santana de Aguiar R., Pedra de Souza R. Systematic review of host genetic association with Covid-19 prognosis and susceptibility: What have we learned in 2020? Rev. Med. Virol. 2022;32:e2283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420453</ArticleId><ArticleId IdType="pubmed">34338380</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Lu W., Ren Y., Fu Y., Martens Y.A., Shue F., Davis M.D., Wang X., Chen K., Li F., et al. Apolipoprotein E regulates lipid metabolism and alpha-synuclein pathology in human iPSC-derived cerebral organoids. Acta Neuropathol. 2021;142:807&#x2013;825. doi: 10.1007/s00401-021-02361-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02361-9</ArticleId><ArticleId IdType="pmc">PMC8500881</ArticleId><ArticleId IdType="pubmed">34453582</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieter C., Brondani L.A., Leit&#xe3;o C.B., Gerchman F., Lemos N.E., Crispim D. Genetic polymorphisms associated with susceptibility to COVID-19 disease and severity: A systematic review and meta-analysis. PLoS ONE. 2022;17:e0270627. doi: 10.1371/journal.pone.0270627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270627</ArticleId><ArticleId IdType="pmc">PMC9258831</ArticleId><ArticleId IdType="pubmed">35793369</ArticleId></ArticleIdList></Reference><Reference><Citation>Safdari Lord J., Soltani Rezaiezadeh J., Yekaninejad M.S., Izadi P. The association of APOE genotype with COVID-19 disease severity. Sci. Rep. 2022;12:13483. doi: 10.1038/s41598-022-17262-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-17262-4</ArticleId><ArticleId IdType="pmc">PMC9356041</ArticleId><ArticleId IdType="pubmed">35931737</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkouskou K., Vasilogiannakopoulou T., Andreakos E., Davanos N., Gazouli M., Sanoudou D., Eliopoulos A.G. COVID-19 enters the expanding network of apolipoprotein E4-related pathologies. Redox Biol. 2021;41:101938. doi: 10.1016/j.redox.2021.101938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.101938</ArticleId><ArticleId IdType="pmc">PMC7943392</ArticleId><ArticleId IdType="pubmed">33730676</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Chen Y., Ke Q., Wang Y., Gong Z., Chen X., Cai Y., Li S., Sun Y., Peng X., et al. ApoE4 associated with severe COVID-19 outcomes via downregulation of ACE2 and imbalanced RAS pathway. J. Transl. Med. 2023;21:103. doi: 10.1186/s12967-023-03945-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-03945-7</ArticleId><ArticleId IdType="pmc">PMC9910247</ArticleId><ArticleId IdType="pubmed">36759834</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: Current definition. Infection. 2022;50:285&#x2013;286. doi: 10.1007/s15010-021-01696-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Arendt-Nielsen L., D&#xed;az-Gil G., G&#xf3;mez-Esquer F., Gil-Crujera A., G&#xf3;mez-S&#xe1;nchez S.M., Ambite-Quesada S., Palomar-Gallego M.A., Pellicer-Valero O.J., Giordano R. Genetic association between ACE2 (rs2285666 and rs2074192) and TMPRSS2 (rs12329760 and rs2070788) polymorphisms with post-COVID symptoms in previously hospitalized COVID-19 survivors. Genes. 2022;13:1935. doi: 10.3390/genes13111935.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13111935</ArticleId><ArticleId IdType="pmc">PMC9690177</ArticleId><ArticleId IdType="pubmed">36360172</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Arendt-Nielsen L., D&#xed;az-Gil G., Gil-Crujera A., G&#xf3;mez-S&#xe1;nchez S.M., Ambite-Quesada S., Palomar-Gallego M.A., Pellicer-Valero O.J., Giordano R. ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors. J. Infect. 2023;86:e67&#x2013;e69. doi: 10.1016/j.jinf.2022.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.12.026</ArticleId><ArticleId IdType="pmc">PMC9794395</ArticleId><ArticleId IdType="pubmed">36584771</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk factors associated with post-COVID-19 condition: A systematic review and meta-analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti M.K., Al-Sarraj Y.A., Albagha O., Yassine H.M. Host genetic variants potentially associated with SARS-CoV-2, A multi-population analysis. Front. Genet. 2020;11:578523. doi: 10.3389/fgene.2020.578523.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2020.578523</ArticleId><ArticleId IdType="pmc">PMC7567011</ArticleId><ArticleId IdType="pubmed">33133166</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumsden A.L., Mulugeta A., Zhou A., Hypp&#xf6;nen E. Apolipoprotein E (APOE) genotype-associated disease risks: A phenome-wide, registry-based, case-control study utilising the UK Biobank. EBioMedicine. 2020;59:102954. doi: 10.1016/j.ebiom.2020.102954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102954</ArticleId><ArticleId IdType="pmc">PMC7452404</ArticleId><ArticleId IdType="pubmed">32818802</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., de Oliveira M.H.S., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., Pangilinan F.C., Pastrana A., Goldrich N., Kavteladze D., et al. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19, A systematic review and meta-analysis. J. Clin. Med. 2022;11:7314. doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Torres-Macho J., Velasco-Arribas M., Plaza-Canteli S., Arias-Naval&#xf3;n J.A., Hern&#xe1;ndez-Barrera V., Guijarro C. Preexisting hypertension is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: A case-control study. J. Hum. Hypertens. 2022;36:582&#x2013;584. doi: 10.1038/s41371-022-00660-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-022-00660-6</ArticleId><ArticleId IdType="pmc">PMC8853057</ArticleId><ArticleId IdType="pubmed">35173268</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Guijarro C., Torres-Macho J., Velasco-Arribas M., Plaza-Canteli S., Hern&#xe1;ndez-Barrera V., Arias-Naval&#xf3;n J.A. Diabetes and the risk of long-term post-COVID symptoms. Diabetes. 2021;70:2917&#x2013;2921. doi: 10.2337/db21-0329.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db21-0329</ArticleId><ArticleId IdType="pubmed">34580087</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Are patients exhibiting post-coronavirus disease (COVID) symptoms at 12 months the same at 5 or 9 months? The fluctuating nature of post-COVID. Clin. Infect. Dis. 2022;75:e1208. doi: 10.1093/cid/ciac007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac007</ArticleId><ArticleId IdType="pmc">PMC9383161</ArticleId><ArticleId IdType="pubmed">34989807</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>